RESUMEN
BACKGROUND AND PURPOSE: University of Kentucky developed a fully virtual course to educate global health learners about the COVID-19 pandemic and compare country responses to it. EDUCATIONAL ACTIVITY AND SETTING: Forty-three students participated in 13 weeks of synchronous interprofessional group meetings via Zoom (Zoom Video Communications, Inc) and asynchronous modules. Interprofessionality was intentional yet implicit, and a flipped classroom was utilized. Assessment was accomplished with one instrument measuring learning outcomes associated with select Consortium of Universities of Global Health Interprofessional Global Health Competencies, Association of American Colleges and Universities Global Learning Value Rubric competencies, and course satisfaction and effectiveness utilizing a retrospective pre-/post-methodology. FINDINGS: Positive pre-/post-change was observed in 10 survey items. Evaluation results concerning course structure and experience were uniformly high, with the key informant interview rated most helpful. Items with significant improvement included a better understanding of the student's place in the world; improved interprofessional communication skills; population health data skills; and understanding of health systems and entities that influence global health and development. Learners appreciated the value of interprofessional teamwork and gained a deeper understanding of the roles and training of colleagues from other programs, leading to a deeper understanding of the actions those professions may take within health systems. SUMMARY: The pivot to all online global health education was a viable solution to addressing the pause in global travel and study abroad experiences at University of Kentucky.
Asunto(s)
COVID-19 , Educación a Distancia , Humanos , Estados Unidos , Pandemias , Estudios Retrospectivos , AprendizajeRESUMEN
The objective of this study was to identify and quantify barriers to generic substitution of antiseizure medications (ASM). A questionnaire on generic ASM substitution was developed by the International League Against Epilepsy (ILAE) Task Force on Generic Substitution. Questions addressed understanding of bioequivalence, standards for generic products, experiences with substitution, and demographic data. The survey was web-based and distributed to ILAE chapters, their membership, and professional colleagues of task force members. Comparisons in responses were between ILAE regions and country income classification. A total of 800 individuals responded, with 44.2% being from the Asia-Oceania ILAE Region and 38.6% from European Region. The majority of respondents had little or no education in generic substitution or bioequivalence. Many respondents indicated lack of understanding aspects of generic substitution. Common barriers to generic substitution included limited access, poor or inconsistent quality, too expensive, or lack of regulatory control. Increase in seizures was the most common reported adverse outcome of substitution. Of medications on the World Health Organization Essential Medication list, problems with generic products were most frequent with carbamazepine, lamotrigine, and valproic acid. Several barriers with generic substitution of ASM revolved around mistrust of regulatory control and quality of generic ASM. Lack of education on generic substitution is also a concern. Generic ASM products may be the only option in some parts of the world and efforts should address these issues. Efforts to address these barriers should improve access to medications in all parts of the world.
Asunto(s)
Sustitución de Medicamentos , Epilepsia , Anticonvulsivantes/uso terapéutico , Medicamentos Genéricos/uso terapéutico , Epilepsia/tratamiento farmacológico , Humanos , Lamotrigina , Encuestas y CuestionariosRESUMEN
Objective. The primary objective of this study was to gain an understanding of student pharmacist learning that occurs during international advanced pharmacy practice experiences (APPEs). The secondary objective was to direct the development of suitable predeparture orientation activities for pharmacy students.Methods. University of Kentucky College of Pharmacy students authored blogs between 2012 and 2019 describing patient care and non-patient care international APPEs. This study utilized inductive thematic analysis to analyze the blogs and define codes, categories, and themes from the data set. The entire data set was used to generate changes to an orientation program delivered to students before they study abroad (predeparture orientation).Results. The analysis included 47 blogs from which seven pictorial codes and 24 text codes were isolated to ultimately form four categories: Learning About Health Care; My Surroundings; Logistics; and Me, Myself, and I. Two overall themes emerged from the codes and categories: Everything Is Different and Here's What I Think and Feel. Through examining the data and reviewing other studies focusing on study abroad experiences, the results indicate that the themes isolated in this study parallel previously described benefits of studying abroad. Additionally, analysis of the blogs suggested that expanding the predeparture orientation for students and including follow-up discussions may facilitate student understanding prior to travel.Conclusion. This study gives unique insight into thoughts and the relative importance of pharmacy students' experiences while studying abroad. The resulting data, considered along with previously published studies, can guide educators in refining predeparture materials. Further studies are needed to evaluate the effectiveness of revised predeparture orientation.
Asunto(s)
Educación en Farmacia , Servicios Farmacéuticos , Farmacia , Estudiantes de Farmacia , Educación en Farmacia/métodos , Humanos , FarmacéuticosRESUMEN
OBJECTIVE: To develop a mentor-supervised, interprofessional, geriatric telemedicine experiential education project in response to the COVID-19 pandemic. METHOD: Medical and pharmacy students collaborated via remote consultations to address the coexistence of multimorbidity and polypharmacy in geriatric patients. In-depth interviews of students and patients as well as Likert scale-based telephonic survey were performed for a comprehensive evaluation of the project's significance. RESULTS: To date, 49 consultations have been conducted. Remote consultations performed by medical and pharmacy students working collaboratively were beneficial for both students, participants. CONCLUSIONS AND PRACTICE IMPLICATIONS: This experimental education project provided students with authentic challenges while simultaneously delivering care to the older adults who are susceptible to disruption of care associated with the pandemic. Further development and expanded implementation of such approaches may be a post-pandemic practice to provide more accessible care for senior patients while incorporating interprofessional education.
RESUMEN
Epilepsy, although common, remains difficult to treat with as much as 30% of patients having treatment-resistant conditions. Lennox-Gastaut syndrome and Dravet syndrome are childhood-onset epilepsies and among the most difficult to treat. Cannabidiol has been approved by the Food and Drug Administration to treat these conditions in individuals over 2 years of age; however, there is a great deal of interest in off-label use. This article examines 3 cases: 1 of a patient with Lennox-Gastaut syndrome, 1 of off-label use of cannabidiol to treat epilepsy, and 1 of nonprescription forms of cannabidiol to treat epilepsy.
RESUMEN
Objective. To engage health professions students in a photo and caption sharing methodology to stimulate reflection and inculcate principles related to global health at a formative time in training. Methods. Undergraduate and graduate students from multiple colleges enrolled in a course that would prepare them for an in-country global health experience. As part of the course, participants took photos to illustrate one of three topics: global health ethics, interprofessional practice, or social determinants of health. The iterative and participatory photovoice process was used for students to analyze, discuss, and reflect on their work in country and upon return. Final photos with captions were displayed online. Researchers analyzed photos and captions using content analysis to identify unifying themes. All students were required to complete the photovoice assignment, but only those who gave informed consent were included in the qualitative analysis. Results. Twenty-six students were included in the analysis. Two overarching themes emerged: revelation and adaptation. Revelation encompassed novel elements that surprised the students, including differences and similarities between the United States and Ecuador. Coded segments related to adaptation discussed participants' resourcefulness while challenging work environments, and how they would apply this new perspective to their future practice in the United States. Conclusion. This global health photovoice project provided a unique medium for reflection for health care trainees. This project enhanced our understanding of the learners' perspectives and this new means of expression offered the learners a greater opportunity for deeper reflection. The assignment also revealed gaps in learning related to social determinants of health and areas of concern related to solidarity and privilege.
Asunto(s)
Salud Global , Intercambio Educacional Internacional , Aprendizaje , Narración , Fotograbar , Estudiantes del Área de la Salud/psicología , Escritura , Ecuador , Humanos , Relaciones Interprofesionales , Determinantes Sociales de la Salud , Estados UnidosRESUMEN
Migraine is the third-most prevalent disease in the world and affects approximately 39 million individuals in the United States alone. Migraine occurs in nearly 1 in 7 individuals between 15 and 49 years of age and is 3 times more frequent in women than in men. The Food and Drug Administration (FDA) recently approved 3 new humanized monoclonal antibodies that target calcitonin gene-related peptide (CGRP): erenumab, fremanezumab, and galcanezumab. The agents either bind to the CGRP receptor (erenumab) or bind to the CGRP ligand (fremanezumab and galcanezumab) and block its binding to the receptor. All 3 products are indicated for preventative treatment of episodic or chronic migraine in adults. The available studies to date document that these agents reduce migraine attacks. The CGRP monoclonal antibodies offer patients new options once they have exhausted other treatments.
Asunto(s)
Anticuerpos Monoclonales Humanizados/uso terapéutico , Anticuerpos Monoclonales/uso terapéutico , Antagonistas del Receptor Peptídico Relacionado con el Gen de la Calcitonina/uso terapéutico , Trastornos Migrañosos/prevención & control , Aprobación de Drogas , Humanos , Trastornos Migrañosos/tratamiento farmacológicoRESUMEN
To establish and maintain successful global pharmaceutical and health care partnerships, pharmacists, pharmacy educators, and students should first learn more about the political, cultural, economic and health care dynamics that affect all of the parties involved in these arrangements. This paper explores Latin America within the context of transnational pharmacy and health-based engagement, including pharmacy-related concepts, health care and cultural considerations, behavioral health perspectives, and common misconceptions. Expert knowledge and experience were used to support and corroborate the existing literature about cultural dynamics of health. Recommendations are provided for how schools and colleges of pharmacy can enhance engagement in culturally sensitive partnerships within Latin America. Health-based profiles of Argentina, Brazil, Ecuador, Guatemala, and Mexico are presented to serve as models for establishing, enhancing, and maintaining partnerships across Latin America.
Asunto(s)
Competencia Cultural , Atención a la Salud/organización & administración , Educación en Farmacia/organización & administración , Servicios Farmacéuticos/organización & administración , Docentes de Farmacia/organización & administración , Humanos , Cooperación Internacional , América Latina , Estudiantes de Farmacia , Estados UnidosRESUMEN
INTRODUCTION: Depression is a common non-motor symptom in Parkinson disease (PD), occurring in approximately 20% of patients with PD. While depression can occur anytime in the disease process, it predates PD diagnosis in about 30% of patients. Between 20% and 60% of depressed patients with PD are either without recognition or treatment of their depression. AREAS COVERED: The pathophysiology of depression in PD is unclear. There are several structural changes seen in depressed patients with PD that are also seen in patients with depression. In addition, the neurotransmitters dopamine, serotonin, and norepinephrine are all depleted in PD. This article covers the pharmacological treatment of depression in PD; this involves standard antidepressant treatment such as selective serotonin reuptake inhibitors, tricyclic antidepressants, serotonin and norepinephrine reuptake inhibitors, and monoamine oxidase inhibitors. As with depression not associated with PD, most treatment is partially successful. Non-pharmacological approaches are also touched upon. EXPERT OPINION: Most antidepressant therapy shows partial efficacy in patients with PD. However, there is a need for better study design as well as more comparative studies for the treatment of depression in PD. Biomarkers will help identify patients with PD and depression earlier in the future.
Asunto(s)
Antidepresivos/uso terapéutico , Trastorno Depresivo/tratamiento farmacológico , Enfermedad de Parkinson/patología , Biomarcadores/metabolismo , Citocinas/metabolismo , Trastorno Depresivo/diagnóstico , Trastorno Depresivo/etiología , Ejercicio Físico , Humanos , Inhibidores de la Monoaminooxidasa/uso terapéutico , Neurotransmisores/metabolismo , Enfermedad de Parkinson/complicaciones , Inhibidores Selectivos de la Recaptación de Serotonina/uso terapéuticoRESUMEN
Objective. To define course objectives for a model global health course in a pharmacy curriculum. Methods. A modified Delphi process was used to determine a consensus among proposed course objectives. A three-round email panel was sent to members of three special interest groups (SIGs) within the American Association of Colleges of Pharmacy (Public Health, Global Pharmacy Education, and Health Disparities and Cultural Competence) to recruit educators broadly interested or engaged in this area of education. An initial list of 80 potential course objectives across 11 domains was proposed for inclusion. Objectives that were cumulatively rated as either "extremely important" or "very important" by at least 75%, 80%, and 85% of respondents in each of the three rounds, respectively, were moved forward (first and second rounds) or accepted (third round). Results. Responses were received from 87, 73, and 70 faculty panel members in the three consecutive rounds. The initial list of proposed objectives was narrowed to 65 objectives (19% reduction), and 38 objectives (53%) after the first and second rounds, respectively. The final list was composed of 20 objectives from seven domains. Global burden of disease and social/environmental determinants of health contained the most objectives selected by consensus. Conclusion. The process identified a consensus for course objectives for a model global health education course. These objectives can be used by pharmacy faculty to align global health education in the profession.
Asunto(s)
Docentes de Farmacia/psicología , Salud Global/educación , Servicios Farmacéuticos , Curriculum , Técnica Delphi , Educación en Farmacia , Evaluación Educacional , Humanos , Sociedades Farmacéuticas , Estudiantes de Farmacia , Estados UnidosRESUMEN
First described almost 50 years ago, chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune disorder characterized by progressive peripheral neuropathy. CIDP is difficult to diagnose, but early diagnosis can be crucial to prevent permanent nerve damage. Initial treatment options include corticosteroids, immunoglobulin given by intravenous administration, and therapeutic plasma exchange. Subcutaneous administration of immunoglobulin provides a new option for patients with CIDP that has the potential to increase independence and improve tolerability. This article reviews the epidemiology, diagnosis, treatment options for first- and second-line therapy, treatment guidelines, and monitoring parameters for CIDP.
Asunto(s)
Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante/diagnóstico , Corticoesteroides/uso terapéutico , Costo de Enfermedad , Humanos , Inmunoglobulinas Intravenosas/uso terapéutico , Aceptación de la Atención de Salud , Intercambio Plasmático , Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante/economía , Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante/epidemiología , Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante/terapiaRESUMEN
The objective of this article is to describe the key areas of consideration for global/international advanced pharmacy practice experience (G/I APPE) preceptors, students and learning objectives. At the 2013 Annual Meeting of the American Association of Colleges of Pharmacy (AACP), the GPE SIG prepared and presented an initial report on the G/IAPPE initiatives. Round table discussions were conducted at the 2014 AACP Annual Meeting to document GPE SIG member input on key areas in the report. Literature search of PubMed, Google Scholar and EMBASE with keywords was conducted to expand this report. In this paper, considerations related to preceptors and students and learning outcomes are described. Preceptors for G/I APPEs may vary based on the learning outcomes of the experience. Student learning outcomes for G/I APPEs may vary based on the type of experiential site. Recommendations and future directions for development of G/IAPPEs are presented. Development of a successful G/I APPE requires significant planning and consideration of appropriate qualifications for preceptors and students.
Asunto(s)
Educación en Farmacia/métodos , Evaluación Educacional/métodos , Internacionalidad , Residencias en Farmacia/métodos , Preceptoría/métodos , Competencia Clínica , Congresos como Asunto/tendencias , Educación en Farmacia/tendencias , Humanos , Residencias en Farmacia/tendencias , Preceptoría/tendencias , Facultades de Farmacia/tendencias , Estudiantes de FarmaciaRESUMEN
OBJECTIVE: To review the pharmacology and clinical data for teriflunomide in relapsing multiple sclerosis (MS). DATA SOURCES: A literature search from 1966 to May 2013 using PubMed/MEDLINE, Web of Science, International Pharmaceutical Abstracts, Academic Search Premiere, Science Citation Index, and the national clinical trials registry was performed using the terms teriflunomide, HMR1726, and A771726. All articles containing human clinical trial data and relevant pharmacologic information were reviewed. STUDY SELECTION/DATA EXTRACTION: Phase 2 and phase 3 clinical trials for teriflunomide were evaluated. All peer-reviewed articles with clinically relevant information were reviewed. Priority for inclusion was placed on randomized controlled trials. DATA SYNTHESIS: Three phase 2 and three phase 3 clinical trials have evaluated teriflunomide as monotherapy or as adjunctive therapy in approximately 3000 patients with relapsing forms of MS. The phase 3 studies used annualized relapse rate, magnetic resonance imaging changes, and Expanded Disability Status Scale scores as outcome measures. One additional Phase 3 clinical study is ongoing. The annualized relapse rates and magnetic resonance imaging findings were improved compared to those with placebo and similar to or improved compared with those with subcutaneously administered interferon-ß-1a 44 µg thrice weekly. Durability of response is supported by open-label extension studies. Common adverse events include increased liver function enzymes, alopecia, diarrhea, influenza, nausea, and paresthesias. Treatment discontinuation was not common and occurred in approximately 10% of patients in phase 3 studies. CONCLUSIONS: Teriflunomide is an effective and safe oral treatment option for relapsing MS. It can be used as monotherapy or added to an interferon or glatiramer acetate. It reduces the rate of relapse and may slow disease progression. The advantages of this drug are the convenience of oral administration and good tolerability. The disadvantage is the lack of long-term safety data and data about the benefit of combination therapy.
Asunto(s)
Crotonatos/uso terapéutico , Inmunosupresores/uso terapéutico , Esclerosis Múltiple Recurrente-Remitente/tratamiento farmacológico , Toluidinas/uso terapéutico , Animales , Crotonatos/farmacología , Interacciones Farmacológicas , Humanos , Hidroxibutiratos , Inmunosupresores/farmacología , Nitrilos , Toluidinas/farmacologíaRESUMEN
OBJECTIVES. To examine the interest of pharmacy students in international study, the demographic factors and involvement characteristics associated with that interest, and the perceived advantages and barriers of engaging in international opportunities during pharmacy school. METHODS. A self-administered electronic survey instrument was distributed to first-, second-, and third-year pharmacy students at the University of Kentucky College of Pharmacy. RESULTS. There were 192 total respondents, for a response rate of 50.9%. Seventy-two percent reported interest in international study. Previous international study experience (p=0.001), previous international travel experience (p=0.002), year in pharmacy school (p=0.03), level of academic involvement (p<0.001), and level of diversity involvement (p<0.001) were associated with international study interest. Positive influences to international study included desire to travel and availability of scholarships. Perceived barriers included an inability to pay expenses and lack of foreign language knowledge. CONCLUSIONS. The needs and interests of pharmacy students should be considered in the development and expansion of internationalization programs in order to effectively optimize global partnerships and available international experiences. Colleges and schools of pharmacy should engage students early in the curriculum when interest in study-abroad opportunities is highest and seek to alleviate concerns about expenses as a primary influence on study-abroad decisions through provision of financial assistance.
Asunto(s)
Curriculum/tendencias , Educación en Farmacia/tendencias , Internacionalidad , Motivación , Estudiantes de Farmacia/psicología , Encuestas y Cuestionarios , Adulto , Características Culturales , Educación en Farmacia/métodos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto JovenRESUMEN
Ischemic stroke is a prevalent disease with a large burden on the health system. It is essential for practitioners caring for patients who have experienced an ischemic stroke to be familiar with the literature supporting both acute management as well as secondary preventive strategies. Due to the large amount of literature available on this topic, this bibliography (the second of a two-part series) aims to provide a comprehensive resource for medical practitioners charged with caring for this population. Acute management strategies involve controlling patients' blood pressure and administering thrombolysis (either pharmacologic or mechanical) to improve blood flow and preserve neurologic function. Various neuroprevention strategies have also been investigated. Secondary prevention strategies, similar to primary prevention, focus on modulation of various risk factors including antiplatelet treatments and control of blood pressure, and lipid levels, amongst others.
Asunto(s)
Isquemia Encefálica/prevención & control , Guías de Práctica Clínica como Asunto , Accidente Cerebrovascular/prevención & control , Presión Sanguínea , Isquemia Encefálica/epidemiología , Isquemia Encefálica/etiología , Humanos , Trombolisis Mecánica/métodos , Factores de Riesgo , Prevención Secundaria/métodos , Accidente Cerebrovascular/epidemiología , Accidente Cerebrovascular/etiología , Terapia Trombolítica/métodosRESUMEN
Ischemic stroke is a prevalent disease with a large burden on the health system. Preventive strategies, therefore, are paramount. Primary prevention is aimed at reducing the risk of stroke in asymptomatic people. The most effective prevention is through control of modifiable risk factors. Due to the large amount of literature available on this topic, this bibliography (the first of a 2-part series) aims to provide a comprehensive resource for medical practitioners charged with caring for this population.
Asunto(s)
Isquemia Encefálica/prevención & control , Guías de Práctica Clínica como Asunto , Accidente Cerebrovascular/prevención & control , Isquemia Encefálica/epidemiología , Isquemia Encefálica/etiología , Humanos , Prevención Primaria/métodos , Factores de Riesgo , Accidente Cerebrovascular/epidemiología , Accidente Cerebrovascular/etiologíaRESUMEN
The use of generic antiepileptic drugs (AEDs) in patients with epilepsy is controversial. The purpose of this study is to identify patient characteristics associated with increased odds of receiving a generic AED product. A large commercial database was used to identify patients with a primary diagnosis of epilepsy who were prescribed an AED during a three-month window. Data analysis found that those ≥65 years old had 15.7% greater odds of receiving a generic AED (OR = 1.157; 95% CI = 1.056-1.268). Patients with Medicaid were found to have 2.44 times the odds of having had a generic AED prescription (OR = 2.44; CI = 2.168-2.754). Patients residing in the Northeast had 12.6% decreased odds of receiving a generic AED (OR = 0.874; C I= 0.821-0.931). These patient characteristics could signify certain health care disparities and may represent potential confounders to future observational studies.
Asunto(s)
Anticonvulsivantes/uso terapéutico , Prescripciones de Medicamentos/estadística & datos numéricos , Medicamentos Genéricos/uso terapéutico , Epilepsia/tratamiento farmacológico , Epilepsia/epidemiología , Adolescente , Adulto , Factores de Edad , Anciano , Niño , Preescolar , Estudios Transversales , Femenino , Humanos , Lactante , Recién Nacido , Seguro , Cobertura del Seguro/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Estados Unidos/epidemiología , Adulto JovenRESUMEN
For many questions related to the pharmacotherapy of epilepsy, there are few or no published data. This lack of data presents dilemmas to practitioners who must make informed, rational decisions about therapy on a daily basis and to policymakers dealing with drug formulary management and reimbursement. Reliance on randomized, clinical trial data is inefficient because of the extensive time and expense involved in conducting a study and the inability to answer every question encountered in practice. In addition, results from randomized, clinical studies are not fully applicable in the clinical setting because of short trial duration and the frequent use of surrogate controls that are rarely seen in routine practice.
RESUMEN
The aim of this study is to determine whether calcium and vitamin D supplementation reduces the risk of bone fractures in adult epilepsy patients. Records were obtained on 7716 patients with epilepsy prescribed antiepileptic drugs (AED) from the Veteran Affairs Hospital in Lexington, Kentucky. We performed a single center, retrospective cohort study to examine the proportion of fractures in 3303 patients on AED who took supplements compared to patients on AED not taking supplements. Patients prescribed long-term AEDs taking calcium and vitamin D were as likely to have fractures as those who did not take these supplements (11.7% vs. 9.9%, χ(2)=0.59, p=0.44). Phenytoin use was associated with a statistically significant increased risk of fractures OR=1.55 (1.10-2.24). Thus, in this group of patients with epilepsy on AED, bone fractures were not prevented in individuals taking calcium and vitamin D supplementation.